miRNA-124a has been shown to function as a tumor suppressor by targeting Receptor for Activated Protein C Kinase (RACK1) in cutaneous melanoma (58) and the histone methyltransferase Enhancer of Zest Homolog 2 (EZH2) in uveal melanoma (59). This evidence concerns the gene RACK1 and cutaneous melanoma.